XML 20 R6.htm IDEA: XBRL DOCUMENT v3.3.1.900
CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Series E-1 Redeemable Convertible Preferred Stock
Series B Redeemable Convertible Preferred Stock
Series C Redeemable Convertible Preferred Stock
Series D-1 Redeemable Convertible Preferred Stock
Series F Redeemable Convertible Preferred Stock
Series A Redeemable Convertible Preferred Stock
Class A and Class B Common Stock
Crocodoc Inc
Crocodoc Inc
Class A and Class B Common Stock
Redeemable Convertible Preferred Stock
Additional Paid-in Capital
Additional Paid-in Capital
Crocodoc Inc
Treasury Stock
Accumulated Other Comprehensive Income
Accumulated Deficit
Balance, Beginning at Jan. 31, 2013 $ (183,656)             $ 1     $ 281,899 $ 10,129   $ (1,177)   $ (192,609)
Balance, Beginning, Shares at Jan. 31, 2013               10,429,000     69,999,000          
Issuance of Stock   $ 99,944                            
Issuance of Stock (in shares)   5,555,000                            
Issuance of redeemable convertible preferred stock exercise of warrants 10,000   $ 6,669 $ 3,168 $ 1,196                      
Issuance of redeemable convertible preferred stock exercise of warrants (in shares)     423,000 199,000 62,000                      
Issuance of common stock in connection with acquisition                 $ 4,742       $ 4,742      
Issuance of common stock in connection with acquisition (in shares)                   813,000            
Issuance of common stock upon exercise of stock options 2,077                     2,077        
Issuance of common stock upon exercise of stock options (in shares)               2,268,000                
Stock-based compensation related to stock awards 11,749                     11,749        
Stock-based compensation related to stock awards (in shares)               395,000                
Issuance of common stock in connection with the purchase of intangible assets 324                     324        
Issuance of common stock in connection with the purchase of intangible assets (in shares)               50,000                
Vesting of early exercised stock options 1,135                     1,135        
Accretion of redeemable convertible preferred stock to redemption value (341)                   $ 341 (341)        
Other comprehensive income (loss) 15 [1]                           $ 15  
Net loss (168,557)                             (168,557)
Balance, Ending at Jan. 31, 2014 (332,512)             $ 1     $ 393,217 29,815   (1,177) 15 (361,166)
Balance, Ending, Shares at Jan. 31, 2014               13,955,000     76,238,000          
Issuance of Stock 181,477         $ 149,614   $ 2       181,475        
Issuance of Stock (in shares)           7,500,000   14,375,000                
Issuance of redeemable convertible preferred stock exercise of warrants 1,220           $ 1,220                  
Issuance of redeemable convertible preferred stock exercise of warrants (in shares)             85,000                  
Issuance of common stock in connection with acquisition 5,239                     5,239        
Issuance of common stock in connection with acquisition (in shares)               409,000                
Issuance of common stock upon exercise of stock options $ 5,918                     5,918        
Issuance of common stock upon exercise of stock options (in shares) 2,306,816             2,307,000                
Stock-based compensation related to stock awards $ 31,929                     31,929        
Stock-based compensation related to stock awards (in shares)               343,000                
Vesting of restricted stock units and restricted stock awards, net of shares withheld for employee payroll taxes               38,000                
Employee payroll taxes withheld related to vesting of restricted stock units and restricted stock awards (359)                     (359)        
Vesting of early exercised stock options 684                     684        
Accretion of redeemable convertible preferred stock to redemption value (11,503)                   $ 11,503 (11,503)        
Deemed dividend on the conversion of Series F redeemable convertible preferred stock (2,262)         $ 2,262         $ 2,262 (2,262)        
Deemed dividend on the conversion of Series F redeemable convertible preferred stock (in shares)           4,405,000         4,405,000          
Conversion of redeemable convertible preferred stock to common stock 557,816             $ 9     $ (557,816) 557,807        
Conversion of redeemable convertible preferred stock to common stock (in shares)               88,228,000     (88,228,000)          
Other comprehensive income (loss) (71) [1]                           (71)  
Net loss (168,227)                             (168,227)
Balance, Ending at Jan. 31, 2015 268,129             $ 12       798,743   (1,177) (56) (529,393)
Balance, Ending, Shares at Jan. 31, 2015               119,655,000                
Issuance of common stock in connection with acquisition 6,108                     6,108        
Issuance of common stock in connection with acquisition (in shares)               344,000                
Issuance of common stock upon exercise of stock options $ 7,164                     7,164        
Issuance of common stock upon exercise of stock options (in shares) 2,196,516             2,197,000                
Stock-based compensation related to stock awards $ 59,504                     59,504        
Vesting of restricted stock units and restricted stock awards, net of shares withheld for employee payroll taxes               1,016,000                
Employee payroll taxes withheld related to vesting of restricted stock units and restricted stock awards (10,436)                     (10,436)        
Restricted stock awards granted to non-employees (in shares)               11,000                
Restricted stock awards forfeited due to termination (in shares)               (13,000)                
Vesting of shares subject to repurchase 126                     126        
Repurchase of shares               (24,000)                
Common stock issued under employee stock purchase plan 10,282                     10,282        
Common stock issued under employee stock purchase plan (in shares)               935,000                
Other comprehensive income (loss) (28) [1]                           (28)  
Net loss (202,948)                             (202,948)
Balance, Ending at Jan. 31, 2016 $ 137,901             $ 12       $ 871,491   $ (1,177) $ (84) $ (732,341)
Balance, Ending, Shares at Jan. 31, 2016               124,121,000                
[1] Tax effect was not material